Alnylam Pharmaceuticals, Inc. (ALNY)

324.97 -7.95 (-2.39%) USD  |  NASDAQ  |  Mar 02, 16:00
324.97 0.00 (0.00%) After-Hours: 16:07
More

Alnylam Pharmaceuticals Quarterly Revenue Estimates

Quarterly Revenue Estimates Chart

View Quarterly Revenue Estimates for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Revenue Estimates Range, Past 5 Years

View Quarterly Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Revenue Estimates Benchmarks

View Quarterly Revenue Estimates Benchmarks
Start Trial
Insmed, Inc. Upgrade
Biogen, Inc. Upgrade
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
AbbVie, Inc. Upgrade